Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

71results about How to "Inhibitory function" patented technology

Fu moxibustion traditional Chinese pharmaceutical oil and preparation method thereof

InactiveCN106215157AReach activityAchieve anti-inflammatory and pain-relieving effectNervous disorderAntipyreticAlcoholEucalyptus oil
The invention provides Fu moxibustion traditional Chinese pharmaceutical oil and a preparation method thereof. The traditional Chinese pharmaceutical oil is prepared from the following raw materials in parts by weight: 2 to 8 parts of cortex cinnamomi oil, 5 to 10 parts of wintergreen oil, 5 to 10 parts eucalyptus oil, 1 to 5 parts of mint oil, 1 to 5 parts of rose oil, 1 to 5 parts of lavender oil, 2 to 8 parts of rhizoma acori graminei oil, 2 to 8 parts of clove oil, 1 to 5 parts of ginger oil, and 2 to 8 parts of ethyl alcohol. The Fu moxibustion traditional Chinese pharmaceutical oil has the effects of dispelling the wind, invigorating the blood circulation, dispelling cold, diminishing inflammation, relieving pain, quieting the heart, soothing the nerves and calming. Based on the yin-yang theory in the traditional Chinese medicine theory, the drug effects can be quickly played through exhaling, exterior syndrome relieving and warming of the externally applied drug. Due to the action of the ethyl alcohol, the drug can quickly penetrate through skin and permeate into muscular striae, and the effects of dispelling the wind, invigorating the collateral, diminishing inflammation and relieving pain can be obtained. The kind of medium medicine can dispel cold through warmness to achieve the effects of dispelling the wind, removing cold, clearing heat, diminishing inflammation, invigorating the blood circulation, activating meridians and relieving pain.
Owner:张东旭

Traditional Chinese medicine composition capable of preventing and treating osteoporosis and preparation method thereof

The invention relates to a medicament which is a Chinese traditional medicine composition preventing and treating osteoporosis, also to a preparation method thereof, belonging to the technical field of medicament. The medicament is mainly made from 25-40% of rhizoma drynariae, 20-35% of barrenwort, 10-25% of radix achyranthis bidentatae, 10-25% of eucommia and 5-15% of antler sheets. The preparation processes are weighing rhizoma drynariae, barrenwort, radix achyranthis bidentatae, eucommia and antler sheets, sequentially extracting radix achyranthis bidentatae with alcohol and filtering to obtain filtrate I and dregs, decocting dregs, rhizoma drynariae, barrenwort and antler sheets with water, filtering to obtain filtrate II, combining the filtrate I and II, and concentrating to make into liquid medicine containing active components. The Chinese traditional medicine formulation provided by the invention has low side effect and relatively good effect on preventing and treating primary osteoporosis.
Owner:谢林

Traditional Chinese medicine composition for treating intercostal neuralgia and preparation method of traditional Chinese medicine composition

The invention provides a traditional Chinese medicine composition for treating intercostal neuralgia and a preparation method of the traditional Chinese medicine composition. The traditional Chinese medicine comprises the following internal medicines in parts by weight: 10-20 parts of angelica sinensis, 10-20 parts of astragalus membranaceus, 10-20 parts of root of red-rooted salvia, 10-20 parts of peach kernel, 10-20 parts of flowers carthami, 10-20 parts of rhizoma cyperi, 10-20 parts of radix paeoniae alba, 10-20 parts of caulis spatholobi, 10-20 parts of ligusticum wallichii, 10-20 parts of radix rehmanniae preparata, 10-20 parts of citrus chirocarpus, 10-20 parts of curcuma zedoary, 10-20 parts of large-leaved gentian, 10-20 parts of radix bupleuri, 10-20 parts of radix curcumae and 10-20 parts of inula flower, and the following external medicines in parts by weight: 10-20 parts of caulis spatholobi, 10-20 parts of ligusticum wallichii, 10-20 parts of roots of common peony, 10-20 parts of radices sileris, 10-20 parts of rhizoma bletillae, 10-20 parts of radix angelicae, 10-20 parts of angelica sinensis, 10-20 parts of corydalis tuber, 10-20 parts of tenuifolia, 10-20 parts of roots of red-rooted salvia, 10-20 parts of radix clematidis, 10-20 parts of ground beeltle and10-20 parts of earthworm. The traditional Chinese medicine composition disclosed by the invention is reasonable in compatibility of medicines, and has strong and lasting anti-inflammatory action, the infectious and infectious inflammations can be restricted, congestion is relieved, the permeability of a blood capillary is reduced, reaction of inflammatory cells and the like is restricted, the function of phagocyte is restricted, a lysosome membrane is stabilized, alexin can be prevented from participating into inflammatory response, and tissue damage repair after inflammation is restricted.
Owner:QINGDAO HENGBO INSTR

3-deoxyglucosone and skin

InactiveCN101084235AInhibition of 3DG functionInhibitory functionPeptidesOxidative stressSugar
The invention relates to the discovery that 3-deoxyglucosone (3DG) and other alpha-dicarbonyl sugars associated diseases and disorders are present and produced in the skin. Further, the invention relates to the discovery that amadorase, an enzyme that mediates 3DG synthesis, is also present in the skin. Thus, the invention further relates to methods of inhibiting production and function of 3-deoxyglucosone and other alpha-dicarbonyl sugars in skin thereby treating or prevention various diseases, disorders or conditions. Additionally, the invention relates to treatment of various diseases, disorders or conditions associated with or mediated by oxidative stress since 3DG induces ROS and AGEs, which are associated with the inflammatory response caused by oxidative stress.
Owner:DYNAMIS THERAPEUTICS

Slow virus vector, preparation thereof and application thereof

The invention discloses a slow virus vector. Preparation and application of the slow virus vector comprise the following steps: firstly, aiming at a FoxP3 gene sequence of a mouse, designing specific short hairpin RNA which comprises a sense strand and an antisense strand, and then carrying the short hairpin RNA into pENTR / U6 plasmids; then using a Lenti virus shRNA expression vectors system to carry out slow virus package in 293 FT cells to obtain the slow virus vector carried with the short hairpin RNA; and introducing the slow virus vector carried with the short hairpin RNA into Treg cells of CD4+CD25+ so as to reduce the function of the Treg cells and inhibit the growth of melanoma.
Owner:SUZHOU UNIV

Method for removing bacteria in chlamydomonas reinhardtii culture process through three mixed antibacterial agents

A method for removing bacteria of chlamydomonas reinhardtii through kresoxim-methyl, ampicillin and cefotaxime mixed antibacterial agents comprises the following steps: inoculating mixed and pollutedchlamydomonas through a TAP solid culture medium flat plate, and culturing; preparing a mixed antibacterial agent flat plate which is a TAP solid culture medium in which kresoxim-methyl, ampicillin and cefotaxime are added, and waiting for later use; transferring and marking the mixed and polluted chlamydomonas which is cultured on the TAP solid culture medium to the antibacterial agent mixed TAPsolid culture medium flat plate for culturing; and transferring and marking the antibacterial chlamydomonas from the antibacterial flat plate to a common TAP solid culture medium flat plate to cultureagain. According to the method, kresoxim-methyl, ampicillin and cefotaxime are used in match to effectively remove the bacteria and fungus pollution in the chlamydomonas culture process; the method has the characteristics of being high in wide popularization scope, efficient, and low in toxicity, and is extremely high in value of popularization and application in storing of precious chlamydomonasand accuracy improving of following experiments.
Owner:XUZHOU NORMAL UNIVERSITY

Application of small-molecule inhibitor ML385 in inhibition of tumor cells PD-L1

The invention discloses an application of a small-molecule inhibitor ML385 in the aspect of inhibiting tumor cells PD-L1. Furthermore, the ML385 inhibitor inhibits the function of PD-L1 in tumor cells and activates the anti-tumor immune function of T cells. The embodiment of the invention also provides an application of the small-molecule inhibitor ML385 in the aspect of inhibiting tumor cells PD-L1 and PD-L2. Furthermore, the ML385 inhibitor destroys the core site of PD-L1L2-SE identified by the NRF2 by inhibiting the combination of the NRF2 and the MAF, so that the expression of PD-L1 and PD-L2 is inhibited. The embodiment of the invention further provides a medicine for killing tumor cells, and the medicine is characterized by comprising the small-molecule inhibitor ML385. Furthermore, the medicine further comprises an anti-PD-L1 antibody or an anti-PD-L2 antibody. According to the embodiment of the invention, experiments prove that the small molecule inhibitor ML385 obviously inhibits the expression of PDL1 in breast cancer cells SUM159 and MDA-MB-231.
Owner:NANTONG UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products